常规MRI融合影像组学特征预测较低级别胶质瘤MGMT启动子甲基化状态
本研究回顾性纳入122例病理确诊的较低级别胶质瘤患者,以87例本地患者为训练集、35例癌症影像档案库患者为独立验证集,从3D-CE-T1加权和T2加权MRI提取1702个影像组学特征并构建模型。融合影像组学模型表现最佳,训练集准确度0.849、AUC 0.970(0.939-1.000),验证集准确度0.886、AUC 0.898(0.786-1.000);单序列模型线性组合及临床因素整合未提高性能。
要点
- 融合3D-CE-T1加权与T2加权影像组学特征的模型预测MGMT启动子甲基化状态表现最佳。
- 融合模型验证集准确度0.886、AUC 0.898(0.786-1.000)。
- 单序列模型线性组合及加入临床因素未提高预测性能。
核心结论
- 常规MRI影像组学模型对预测较低级别胶质瘤患者MGMT启动子甲基化状态可靠,融合不同序列的影像组学特征可能提高预测性能。
研究设计与样本
- 回顾性研究,共122例病理确诊的较低级别胶质瘤患者,87例本地患者为训练集,35例来自癌症影像档案库为独立验证集。
诊断标准与关键数值
- 从3D-CE-T1加权和T2加权MRI图像提取1702个影像组学特征,包括14个形状特征、18个一阶特征、75个纹理特征和744个小波特征各分别;采用最小绝对收缩和选择算子算法筛选特征,以受试者工作特征曲线评价模型。
临床应用与阅片要点
- 融合影像组学模型在训练集准确度0.849、AUC 0.970(0.939-1.000)。
- 融合影像组学模型在验证集准确度0.886、AUC 0.898(0.786-1.000)。
- 单序列影像组学模型的线性组合及整合临床因素未提高预测性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter has been proven to be a prognostic and predictive biomarker for lower grade glioma (LGG). This study aims to build a radiomics model to preoperatively predict the MGMT promoter methylation status in LGG.
METHOD: 122 pathology-confirmed LGG patients were retrospectively reviewed, with 87 local patients as the training dataset, and 35 from The Cancer Imaging Archive as independent validation. A total of 1702 radiomics features were extracted from three-dimensional contrast-enhanced T1 (3D-CE-T1)-weighted and T2-weighted MRI images, including 14 shape, 18 first order, 75 texture, and 744 wavelet features respectively. The radiomics features were selected with the least absolute shrinkage and selection operator algorithm, and prediction models were constructed with multiple classifiers. Models were evaluated using receiver operating characteristic (ROC).
RESULTS: Five radiomics prediction models, namely, 3D-CE-T1-weighted single radiomics model, T2-weighted single radiomics model, fusion radiomics model, linear combination radiomics model, and clinical integrated model, were built. The fusion radiomics model, which constructed from the concatenation of both series, displayed the best performance, with an accuracy of 0.849 and an area under the curve (AUC) of 0.970 (0.939-1.000) in the training dataset, and an accuracy of 0.886 and an AUC of 0.898 (0.786-1.000) in the validation dataset. Linear combination of single radiomics models and integration of clinical factors did not improve.
CONCLUSIONS: Conventional MRI radiomics models are reliable for predicting the MGMT promoter methylation status in LGG patients. The fusion of radiomics features from different series may increase the prediction performance.
引用
- Jiang C, Kong Z, Liu S, et al. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas. Eur J Radiol. 2019. PMID: 31704598. doi:10.1016/j.ejrad.2019.108714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。